Statistical evaluation of test-retest studies in PET brain imaging

[1]  M. Lodge.  Repeatability of SUV in Oncologic 18F-FDG PET , 2017, The Journal of Nuclear Medicine.

[2]  M. Pencina,et al.  Critical Review of Current Approaches for Echocardiographic Reproducibility and Reliability Assessment in Clinical Research. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  Claus Svarer,et al.  Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36: Test–retest reproducibility and head-to-head comparison with the antagonist [18F]altanserin , 2016, NeuroImage.

[4]  Richard E Carson,et al.  Imaging the Cannabinoid CB1 Receptor in Humans with [11C] OMAR: Assessment of Kinetic Analysis Methods, Test–Retest Reproducibility, and Gender Differences , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Mithat Gönen,et al.  Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment , 2015, Statistical methods in medical research.

[6]  G. Escaramís,et al.  Distinguishability and agreement with continuous data , 2014, Statistics in medicine.

[7]  C. Halldin,et al.  Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  G Y Zou,et al.  Sample size formulas for estimating intraclass correlation coefficients with precision and assurance , 2012, Statistics in medicine.

[9]  Steven A Julious,et al.  Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data , 2012, Statistics in medicine.

[10]  E. Rabiner,et al.  The Development, Past Achievements, and Future Directions of Brain PET , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  Christine DeLorenzo,et al.  in vivo Variation in Metabotropic Glutamate Receptor Subtype 5 Binding Using Positron Emission Tomography and [11C]ABP688 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  James Robert Brašić,et al.  Evaluation of 11C-ABP688 and 18F-FPEB for imaging mGluR5 receptors in the human brain , 2011 .

[13]  Christine DeLorenzo,et al.  In Vivo Quantification of Human Serotonin 1A Receptor Using 11C-CUMI-101, an Agonist PET Radiotracer , 2010, The Journal of Nuclear Medicine.

[14]  Huiman X Barnhart,et al.  Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets. , 2009, Translational oncology.

[15]  Christine DeLorenzo,et al.  Modeling Considerations for In Vivo Quantification of the Dopamine Transporter using [11C]PE2I and Positron Emission Tomography , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  H. Barnhart,et al.  An Overview on Assessing Agreement with Continuous Measurements , 2007, Journal of biopharmaceutical statistics.

[17]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  R. Parsey,et al.  In vivo Quantification of Serotonin Transporters Using [11C]DASB and Positron Emission Tomography in Humans: Modeling Considerations , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  S. Walter,et al.  Interval estimation and optimal design for the within-subject coefficient of variation for continuous and binary variables , 2006, BMC medical research methodology.

[20]  S. DeKosky,et al.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  S. Julious.  Sample sizes for clinical trials with Normal data , 2004, Statistics in medicine.

[22]  R Todd Ogden,et al.  Estimation of kinetic parameters in graphical analysis of PET imaging data , 2003, Statistics in medicine.

[23]  S. Gunn,et al.  Positron Emission Tomography Compartmental Models , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[26]  H Quan,et al.  Assessing reproducibility by the within-subject coefficient of variation with random effects models. , 1996, Biometrics.

[27]  J. Seibyl,et al.  Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  D R Medoff,et al.  PET‐FDG Test‐Retest Reliability During a Visual Discrimination Task in Schizophrenia , 1993, Journal of computer assisted tomography.

[29]  C. Halldin,et al.  Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  A. Willemsen,et al.  PET and SPECT in Psychiatry , 2014 .

[31]  Andreas Otte,et al.  PET and SPECT in Psychiatry , 2014 .